Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

According to MarketsandMarkets™, the Drug Discovery Technologies Market is projected to grow from about USD 30.58 billion in ...

GenScript Biotech Corporation, a global leader in life science research and biotech solutions, today announced its supporting ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

High-throughput mass spectrometry (HT-MS) has emerged as an indispensable tool in drug discovery, offering rapid, sensitive and label‐free detection of biochemical transformations. By coupling ...

Curious about how protein crystallography fits into modern drug discovery? In this on-demand webinar, Dr. Thomas Pesnot from Concept Life Sciences chats with Dr. Debanu Das of Accelero Biostructure, ...

Sygnature Discovery, an integrated drug discovery contract research organization (CRO), reports that it completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory ...

Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...

A novel optogenetic screening platform enables control over previously intractable biological systems. Using the screening platform, scientists have been able to selectively activate the integrated ...

Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...